Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Target enrollment reached in ASCENT trial of DN-101

Dec. 29, 2003

Exelixis files IND for phase III trial of XL-119

Dec. 29, 2003

Esters of camptothecins with enhanced anticancer activity described in recent patent

Dec. 29, 2003

COX17 as a novel target for NSCLC

Dec. 23, 2003

Mitotic kinesin KSP inhibitors reported by Cytokinetics and GlaxoSmithKline

Dec. 23, 2003

Photobarr PDT recommended for approval in E.U.

Dec. 23, 2003

Array BioPharma and AstraZeneca to develop MEK program for oncology

Dec. 23, 2003

Alexion and XOMA collaborate on c-MPL agonist antibody development

Dec. 23, 2003

Highlights from the 2003 AACR-NCI-EORTC International Conference available on the LifeSci Channel

Dec. 23, 2003

Clinical effects of PKC-412 in acute myeloid leukemia

Dec. 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026